申请人:Bristol-Myers Squibb Company
公开号:US05763444A1
公开(公告)日:1998-06-09
Novel compound of formula I and pharmaceutically acceptable salts thereof are useful CNS agents: ##STR1## wherein X is CH or N; X' is CH or a direct covalent link; Y is CH, CH.sub.2 or N; Y' is N, NH, O or S; R.sup.1 is H, Br, Cl, F, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkoxycarbonyl, CN, CONH.sub.2 or CH.sub.3 SO.sub.2 NH; n is 2 or 3; R.sup.2 is H or C.sub.1-4 alkyl; R.sup.3 is C.sub.1-4 alkoxy; R.sup.4 is H, Br, Cl, or F; and Z is CH or N.
化合物I的新型化合物及其药学上可接受的盐是有用的中枢神经系统药物:##STR1## 其中X为CH或N;X'为CH或直接共价键;Y为CH、CH.sub.2或N;Y'为N、NH、O或S;R.sup.1为H、Br、Cl、F、C.sub.1-4烷基、C.sub.1-4烷氧基、C.sub.1-4烷氧羰基、CN、CONH.sub.2或CH.sub.3SO.sub.2NH;n为2或3;R.sup.2为H或C.sub.1-4烷基;R.sup.3为C.sub.1-4烷氧基;R.sup.4为H、Br、Cl或F;Z为CH或N。